...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: ERA-EDTA posters

Resverlogix left out a few key words from the title of the second abstract. The full title is:

"DESIGN FEATURES OF THE BETONMACE CHRONIC KIDNEY DISEASE SUB-STUDY; EFFECTS OF THE SELECTIVE BET-INHIBITOR APABETALONE ON KIDNEY FUNCTION AND MACE IN POST-ACS PATIENTS WITH ESTIMATED GLOMERULAR FILTRATION RATE BELOW 60 AND DIABETES"

They left out "DESIGN FEATURES OF THE" from the title included in the news release.

If you read the full abstract, this presentation seems to serve as simply a description of the design of the clinical trial/sub-study.....not the results of the sub-study. It is not uncommon for these types of presentations to promote and discuss ongoing clinical trials w/o presenting any data.

BDAZ

Share
New Message
Please login to post a reply